David Ombengi, MPH, MBA is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Duquesne UniversityPharmD, 2003
- Tulane University School of Public Health & Tropical MedicineMPH, Public Health
- Duquesne University/UPMC Medical CenterAcademic Teaching & Research Fellowship, Cardiology/Ambulatory care and Pharmacoeconomics
- University of St. ThomasMaster of Business Administration (MBA), Health Care Management
Professional Memberships
- Member
- Member
- Member
Publications & Presentations
PubMed
- 16 citationsInclisiran: A First-in-Class siRNA Therapy for Lowering Low-Density Lipoprotein Cholesterol.Essie Samuel, Maya Watford, Ugochukwu O Egolum, David N Ombengi, Hua Ling
The Annals of Pharmacotherapy. 2023-03-01 - 28 citationsTafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy:Jonathan Park, Ugochukwu Egolum, Shanea Parker, Ebony Andrews, David Ombengi
The Annals of Pharmacotherapy. 2020-05-01 - 3 citationsExtended Duration Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Peripheral Arterial Disease: A Meta-Analysis.Hua Ling, Ebony Andrews, David Ombengi, Fang Li
Cardiology Research. 2018-06-06
Office
709 Mall Blvd
Savannah, GA 31406Phone+1 912-201-8041
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: